-
2
-
-
0029959685
-
Preparation and evaluation of a compressed tablet rapidly disintegrating in oral cavity
-
Bi Y, Sunada H, Yonezawa Y, Dayo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in oral cavity. Chem Pharm Bull (Tokyo). 1996;44:2121-2127.
-
(1996)
Chem. Pharm. Bull. (Tokyo)
, vol.44
, pp. 2121-2127
-
-
Bi, Y.1
Sunada, H.2
Yonezawa, Y.3
Dayo, K.4
Otsuka, A.5
Iida, K.6
-
3
-
-
0030815948
-
Formulation and production of rapidly disintegrating tablets by lyophilization using hydrochlorthiazide as a model drug
-
Corveleyn S, Remon JP. Formulation and production of rapidly disintegrating tablets by lyophilization using hydrochlorthiazide as a model drug. Int J Pharm. 1997;152:215-225.
-
(1997)
Int. J. Pharm.
, vol.152
, pp. 215-225
-
-
Corveleyn, S.1
Remon, J.P.2
-
4
-
-
33544470567
-
Freeze-dried rapidly disintegrating tablets
-
January 4
-
Remon JP, Corveleyn S. Freeze-dried rapidly disintegrating tablets. US patent 6 010 719. January 4, 2000.
-
(2000)
US Patent 6 010 719
-
-
Remon, J.P.1
Corveleyn, S.2
-
7
-
-
0343273029
-
Rapidly soluble oral dosage forms, method of making same, and composition thereof
-
June 9
-
Roser BJ, Blair J. Rapidly soluble oral dosage forms, method of making same, and composition thereof. US patent 5 762 961. June 9, 1998.
-
(1998)
US Patent 5 762 961
-
-
Roser, B.J.1
Blair, J.2
-
8
-
-
0026656034
-
Prostaglandins, NSAIDs and cytoprotection
-
Wallace JL. Prostaglandins, NSAIDs and cytoprotection. Gastroenterol Clin. North Am. 1992;21:631-641.
-
(1992)
Gastroenterol. Clin. North Am.
, vol.21
, pp. 631-641
-
-
Wallace, J.L.1
-
9
-
-
0034078135
-
Nimesulide: Some pharmaceutical and pharmacological aspects and update
-
Singla AK, Chawla M, Singh A. Nimesulide: some pharmaceutical and pharmacological aspects and update. J Pharm Pharmacol. 2000;52:467-486.
-
(2000)
J. Pharm. Pharmacol.
, vol.52
, pp. 467-486
-
-
Singla, A.K.1
Chawla, M.2
Singh, A.3
-
10
-
-
0027988621
-
The anti-inflammatory drug nimesulide inhibits neutrophil adherence to and migrations across monolayers of cytokine-activated endothelial cells
-
Dapino P, Ottonello L, Dallegri F. The anti-inflammatory drug nimesulide inhibits neutrophil adherence to and migrations across monolayers of cytokine-activated endothelial cells. Respiration. 1994;61:336-341.
-
(1994)
Respiration
, vol.61
, pp. 336-341
-
-
Dapino, P.1
Ottonello, L.2
Dallegri, F.3
-
11
-
-
0030910347
-
Study of the influence of both cyclodextrin and L-lysine on the aqueous solubility of Nimesulide: Isolation and characterization of nimesulide L-lysine-cyclodextrin complexes
-
Piel G, Pirotte I, Delnevvile I, Neven P, Delattre L. Study of the influence of both cyclodextrin and L-lysine on the aqueous solubility of Nimesulide: isolation and characterization of nimesulide L-lysine-cyclodextrin complexes. J Pharm Sci. 1997;86:475-480.
-
(1997)
J. Pharm. Sci.
, vol.86
, pp. 475-480
-
-
Piel, G.1
Pirotte, I.2
Delnevvile, I.3
Neven, P.4
Delattre, L.5
-
12
-
-
0141576825
-
Physicochemical Characterization and dissolution properties of nimesulide-cyclodextrin binary systems
-
Nalluri BN, Chowdary KPR, Murthy KVR, Hayman AR, Becket G. Physicochemical Characterization and dissolution properties of nimesulide-cyclodextrin binary systems. AAPS PharmSciTech. 2003;4(1):E2.
-
(2003)
AAPS PharmSciTech.
, vol.4
, Issue.1
-
-
Nalluri, B.N.1
Chowdary, K.P.R.2
Murthy, K.V.R.3
Hayman, A.R.4
Becket, G.5
-
13
-
-
23144465464
-
Solubility enhancement of cox-2 inhibitors using various solvent systems
-
Seedher N, Bhatia S. Solubility enhancement of cox-2 inhibitors using various solvent systems. AAPS PharmSciTech. 2003;4(3):E33.
-
(2003)
AAPS PharmSciTech.
, vol.4
, Issue.3
-
-
Seedher, N.1
Bhatia, S.2
-
14
-
-
0004186239
-
-
2nd ed. New York, NY: Marcel Decker Inc
-
Bolton S. Pharmaceutical Statistics. 2nd ed. New York, NY: Marcel Decker Inc. 1990:234.
-
(1990)
Pharmaceutical Statistics
, pp. 234
-
-
Bolton, S.1
-
15
-
-
0000137328
-
Experiment design, modeling and optimization strategies for product and process development
-
Libermann HA, Reiger MM, Banker GS, eds. New York, NY: Marcel Dekker Inc
-
Franz RM, Browne JE, Lewis AR. Experiment design, modeling and optimization strategies for product and process development. In: Libermann HA, Reiger MM, Banker GS, eds. Pharmaceutical Dosage Forms: Disperse Systems. Vol 1. New York, NY: Marcel Dekker Inc; 1988;427-519.
-
(1988)
Pharmaceutical Dosage Forms: Disperse Systems
, vol.1
, pp. 427-519
-
-
Franz, R.M.1
Browne, J.E.2
Lewis, A.R.3
-
16
-
-
0031006213
-
New method of preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material
-
Koizumi K, Watanabe Y, Morita K, Utoguchi N, Matsumoto M. New method of preparing high porosity rapidly saliva soluble compressed tablets using mannitol with camphor, a subliming material. Int J Pharm. 1997;152:127-131.
-
(1997)
Int. J. Pharm.
, vol.152
, pp. 127-131
-
-
Koizumi, K.1
Watanabe, Y.2
Morita, K.3
Utoguchi, N.4
Matsumoto, M.5
-
17
-
-
0015535580
-
A new tablet disintegrating agent: Cross-linked polyvinylpyrollidone
-
Kornblum S, Stoopak S. A new tablet disintegrating agent: cross-linked polyvinylpyrollidone. J Pharm Sci. 1973;62:43-49.
-
(1973)
J. Pharm. Sci.
, vol.62
, pp. 43-49
-
-
Kornblum, S.1
Stoopak, S.2
-
18
-
-
33544468078
-
Fast disintegrating solid formulations of anirectam
-
Japanese patent 11 13 662. May 15
-
Shasaku K. Fast disintegrating solid formulations of anirectam. Jpn Kokai Tokyo Koho. Japanese patent 11 13 662. May 15, 1999.
-
(1999)
Jpn. Kokai Tokyo Koho
-
-
Shasaku, K.1
|